Summary of the Valeant group Pharmacovigilance System Version 5
Texte intégral
Documents relatifs
(2) to explore ways and means of increasing the extent and types of WHO 1 s cooperation with Member States in combating this infection; to seek, for that purpose, the necessary
This policy should result in a reduced likeli- hood that forms will be lost; copies of the question- naires would be retained in the health facility for
2.2.3 Spontaneous reporting is dependent on clinicians and other health professionals who need to be trained and encouraged to report details of sus- pected adverse reactions
Percentage of total annual reports satisfactorily completed and submitted to the national pharmacovigilance centre in the previous calendar year.. Subset indicator CP5a: of the
WHO International Classification of Patient Safety Organizational and service factors • Protocols/policies/procedures/process • Organizational decisions/culture • Organization of
Education and training of health professionals in medicine safety, exchange of information between national pharmacovigilance centres, the coordi- nation of such exchange, and
The Amadio/Cardelli type system [Amadio and Cardelli 1993], a certain kind of flow analysis [Palsberg and O’Keefe 1995], and a simple constrained type system [Eifrig et al..
On the 18th July, 2003, the Po River Basin Authority, Civil Protection Department, Emilia Romagna, Lombardia, Valle d’ d’Aosta and Piemonte Regions, the Po Interregional Agency, the
